| Future Health Pharma GmbH - Matrifen 25 ug/h, Transdermales Pflaster | | 57460 | | 01 | | Matrifen 25 ug/h | | Transdermales Pflaster | | N02AB03 | | Fentanyl | | 22.11.2007 | | |
| | Composition | | fentanylum 2.75 mg, dipropylenglycolum, hydroxypropylcellulosum, silicone adhesive, dimeticonum 350, ethyleni et vinylis acetatis polymerisatum, Trägermaterial: poly(ethylenis terephthalas), Drucktinte: Rosa, ad praeparationem pro 8.4 cm² cum liberatione 25 µg/h. | | Packungsbestandteile | | Transdermal System | | | | | | Active Agent | Dose |
|---|
| Fentanyl | 2.75 mg |
| | | | Inactive agents |
|---|
| Dipropylenglycol |
|
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 003 | 5 plaster(s) | PR | PR | A+ | | Yes | | 017 | 10 plaster(s) | PR | PR | A+ | | Yes |
|
|
